SOX10 (SRY-Box Transcription Factor 10) is a critical transcription factor for neural crest development and glial cell differentiation. Mutations in SOX10 cause peripheral demyelinating neuropathy and central nervous system involvement in Waardenburg syndrome type IV. Understanding SOX10's role is essential for studying demyelinating diseases and glial biology in neurodegeneration.
.infobox.infix-gene
; Gene Name
: SOX10
; Full Name
: SRY-Box Transcription Factor 10
; Chromosome
: 22q13.1
; NCBI Gene ID
: 6663
; Ensembl ID
: ENSG00000100146
; UniProt ID
: P56937
; Protein Family
: SOX (SRY-related HMG-box) family
The SOX10 gene encodes a 446-amino acid transcription factor that belongs to the SOX (SRY-related HMG-box) family. SOX10 contains a high mobility group (HMG) DNA-binding domain that recognizes the sequence (A/T)(A/T)CAA(A/T)G in target gene promoters. As a transcription factor, SOX10 regulates gene expression during neural crest development, oligodendrocyte differentiation, and melanocyte development[1].
SOX10 functions both as an activator and repressor depending on protein partners and context. It forms complexes with other transcription factors like Pax3 and MITF to coordinate cell-type specific gene expression programs.
SOX10 is essential for neural crest formation:
In the central nervous system:
In the peripheral nervous system:
SOX10 mutations cause Waardenburg syndrome type IV (Waardenburg-Hirschsprung disease), characterized by:
SOX10 deficiency leads to:
While SOX10 is primarily a developmental transcription factor:
Approaches targeting SOX10:
SOX10 regulates numerous genes:
| Gene | Function | Relevance |
|---|---|---|
| MBP | Myelin Basic Protein | Myelin structure |
| PLP1 | Proteolipid Protein | CNS myelination |
| PMP22 | Peripheral Myelin Protein | PNS myelination |
| MITF | Melanocyte induction | Pigmentation |
| DCT | Dopachrome tautomerase | Melanocyte development |
SOX10-deficient mice (splotch phenotype):
The study of Sox10 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.